This three-day course will begin with an introduction of Von Willebrand Disease through a series of overview lectures. Thereafter, clinical cases will be presented and the management, prognosis, treatment and diagnosis of the disease will be discussed. The course will use an evidence-based approach and participants will review and present scientific articles about Von Willebrand Disease.
International guidelines for the management of Von Willebrand Disease will be distributed. Participants will receive a course binder including the guidelines, articles and lectures, i.e.”take home messages”.
The course is a collaboration between Malmö Centre for Thrombosis and Haemostasis, Lund University, Malmö University Hospital and Octapharma Nordic, Sweden.
LIPUS (Institute for the Professional Development of Physicians in Sweden) has reviewed and approved the course (www.lipus.se). The course is granted 14 European CME credits (ECMEC) by the European Accreditation
Council for Continuing Medical Education (EACCME).
The course is partly financed by Octapharma.